Insider · CIK 0001781954
Ronald G. Tascarella
Files at PBHC (Pathfinder Bancorp, Inc.). First filing -, latest -.
In brief
Ronald G. Tascarella files SEC Form 4 as officer at PBHC (Pathfinder Bancorp, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronald G. Tascarella has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | PBHC Pathfinder Bancorp, Inc. | MOption exercise Common Stock | +2,109 | $11.35 | $24k | 18,636 | Mar 2, 2026 |
| Feb 27, 2026 | PBHC Pathfinder Bancorp, Inc. | MOption exercise Common Stock | -1,865 | $13.42 | $25k | 16,771 | Mar 2, 2026 |
| Feb 27, 2026 | PBHC Pathfinder Bancorp, Inc. | MOption exercise Stock Optionsderivative | -2,109 | $0.00 | $0 | 0 | Mar 2, 2026 |
Questions about Ronald G. Tascarella
Answered from the filings on this page, as of the latest one.
Is Ronald G. Tascarella buying or selling?
Ronald G. Tascarella has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronald G. Tascarella's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald G. Tascarella has 0.
Where does Ronald G. Tascarella file Form 4?
Ronald G. Tascarella has filed Form 4 at PBHC (Pathfinder Bancorp, Inc.) as 1st Vice President. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.